CIS Expands Commercial Compliance Practice with Three Compliance and Ethics Experts

CIS today announced the addition of three new hires, adding significant compliance expertise to its Compliance and Ethics Practice. The addition of these senior compliance professionals will further expand CIS’ offerings that continue to grow rapidly as a result of increased regulatory oversight and client demand for commercial compliance and risk mitigation services.

22
Apr
CIS Event

CIS Quoted in Industry Publication on the Push to Delay New Medicaid Generic Reimbursement Rates

CIS today announced that Sharon H. Greeson, R.Ph, Strategic Consultant, Government Pricing and Programs at CIS, was quoted in Modern Healthcare’s recent article, “Reform Update: Pharmacists call for delay on new Medicaid generic reimbursement rates.” Greeson commented on CMS’ expectation that states implement a new formula mandated under the Patient Protection and Affordable Care Act that will significantly trim Medicaid reimbursement rates for generic drugs.

17
Apr
CIS Event

Evegan Re-elected to Medicaid Drug Rebate Program Advisory Board

CIS today announced that Tom Evegan, Senior Director, Commercial Contracting Services, will serve a second term as an Advisory Board Member on the Institute of International Research (IIR) USA’s 19th Annual Summit on the Medicaid Drug Rebate Program (MDRP), taking place in Chicago on September 15-17, 2014.

8
Apr
CIS Event